Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBS for Adult Encephalitis
NCT06584045Recruiting
- Sponsor
- Tongji Hospital
- Start
- Sep 2024
- Primary completion
- Jul 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of calculus bovis sativus in encephalitis, viral encephalitis and Autoimmune Encephalitis (AE) (3 arms), sponsored by Tongji Hospital. Primary endpoints: Modified Rankin Scale at 12 weeks, Clinical Assessment Scale in Autoimmune Encephalitis at 12 weeks and 1 more. Started Sep 2024; status: recruiting.
02
Drugs
calculus bovis sativus
03
Conditions
encephalitisviral encephalitisAutoimmune Encephalitis (AE)
Beyond the preview
Go deeper on NCT06584045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06584045.